Aspergillus in COVID-19 intensive care unit; what is lurking above your head?

Sue Dailly1, Erin Boatswain2, Julie Brooks1

  • 1Infection Prevention and Control, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Abstract

Insights

A hospital outbreak of Aspergillus infection in intensive care patients was traced to a hidden ceiling water leak. Prompt multidisciplinary investigation and remediation are crucial for preventing such fungal infections.

Area of Science:

  • Infectious Diseases
  • Hospital Epidemiology
  • Environmental Health

Background:

  • The COVID-19 pandemic placed immense strain on healthcare systems, potentially diverting attention from other critical health threats.
  • Aspergillus infections, particularly in immunocompromised intensive care unit (ICU) patients, pose a significant risk.

Purpose of the Study:

  • To investigate an unexpected cluster of Aspergillus infections in a newly opened ICU during the COVID-19 pandemic.
  • To identify the source of Aspergillus contamination and implement control measures.

Main Methods:

  • Routine respiratory sample surveillance identified three patients with Aspergillus.
  • An urgent multidisciplinary outbreak meeting was convened to discuss potential sources and management.
  • Environmental sampling, including settle plates, and investigation of reported water leaks were conducted.

Main Results:

  • Aspergillus growth on a settle plate above a nurse's station indicated the source.
  • Investigation revealed a slow water leak from a pipe above ceiling tiles, leading to pooled water and mold growth.
  • The leak site was above an area with a previously unreported, resolved ceiling water leak.

Conclusions:

  • Prompt notification and thorough investigation of water leaks in patient areas are essential for infection prevention.
  • Multidisciplinary outbreak meetings facilitate rapid identification and remediation of contamination sources.
  • Hospitals must maintain vigilance for concurrent outbreaks and clusters, even during pandemics.

Related Concept Videos

Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.4K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
287
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
319
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
183
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
273
Fungal Phylum Ascomycota01:28

Fungal Phylum Ascomycota

Phylum Ascomycota, a major division within the subkingdom Dikarya, comprises a diverse range of fungal species, including both unicellular yeasts and filamentous molds such as Aspergillus and Penicillium. These fungi thrive in a variety of habitats, from aquatic ecosystems to terrestrial environments, playing crucial ecological and economic roles.Morphology and ReproductionThe defining characteristic of Ascomycetes, commonly referred to as sac fungi, is the ascus—a sac-like structure that...
120